212 related articles for article (PubMed ID: 29661477)
1. Low diastolic blood pressure and adverse outcomes in heart failure with preserved ejection fraction.
Tsujimoto T; Kajio H
Int J Cardiol; 2018 Jul; 263():69-74. PubMed ID: 29661477
[TBL] [Abstract][Full Text] [Related]
2. Diastolic Blood Pressure and Adverse Outcomes in the TOPCAT (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) Trial.
Sandesara PB; O'Neal WT; Kelli HM; Topel M; Samman-Tahhan A; Sperling LS
J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29475874
[TBL] [Abstract][Full Text] [Related]
3. Favorable effects of statins in the treatment of heart failure with preserved ejection fraction in patients without ischemic heart disease.
Tsujimoto T; Kajio H
Int J Cardiol; 2018 Mar; 255():111-117. PubMed ID: 29307549
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of renin-angiotensin system inhibitors for patients with heart failure with preserved ejection fraction and mild to moderate chronic kidney disease.
Tsujimoto T; Kajio H
Eur J Prev Cardiol; 2018 Aug; 25(12):1268-1277. PubMed ID: 29808753
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone.
Shah AM; Claggett B; Sweitzer NK; Shah SJ; Anand IS; Liu L; Pitt B; Pfeffer MA; Solomon SD
Circulation; 2015 Aug; 132(5):402-14. PubMed ID: 26130119
[TBL] [Abstract][Full Text] [Related]
6. Systolic blood pressure and cardiovascular outcomes in heart failure with preserved ejection fraction: an analysis of the TOPCAT trial.
Selvaraj S; Claggett B; Shah SJ; Anand I; Rouleau JL; Desai AS; Lewis EF; Pitt B; Sweitzer NK; Pfeffer MA; Solomon SD
Eur J Heart Fail; 2018 Mar; 20(3):483-490. PubMed ID: 29148144
[TBL] [Abstract][Full Text] [Related]
7. Gender Differences in the Risk of Adverse Outcomes in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction.
O'Neal WT; Sandesara P; Hammadah M; Venkatesh S; Samman-Tahhan A; Kelli HM; Soliman EZ
Am J Cardiol; 2017 Jun; 119(11):1785-1790. PubMed ID: 28395886
[TBL] [Abstract][Full Text] [Related]
8. Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial.
Pfeffer MA; Claggett B; Assmann SF; Boineau R; Anand IS; Clausell N; Desai AS; Diaz R; Fleg JL; Gordeev I; Heitner JF; Lewis EF; O'Meara E; Rouleau JL; Probstfield JL; Shaburishvili T; Shah SJ; Solomon SD; Sweitzer NK; McKinlay SM; Pitt B
Circulation; 2015 Jan; 131(1):34-42. PubMed ID: 25406305
[TBL] [Abstract][Full Text] [Related]
9. Heart rate and the risk of adverse outcomes in patients with heart failure with preserved ejection fraction.
O'Neal WT; Sandesara PB; Samman-Tahhan A; Kelli HM; Hammadah M; Soliman EZ
Eur J Prev Cardiol; 2017 Jul; 24(11):1212-1219. PubMed ID: 28482692
[TBL] [Abstract][Full Text] [Related]
10. Abdominal Obesity Is Associated With an Increased Risk of All-Cause Mortality in Patients With HFpEF.
Tsujimoto T; Kajio H
J Am Coll Cardiol; 2017 Dec; 70(22):2739-2749. PubMed ID: 29191321
[TBL] [Abstract][Full Text] [Related]
11. Peripheral artery disease and risk of adverse outcomes in heart failure with preserved ejection fraction.
Sandesara PB; Hammadah M; Samman-Tahhan A; Kelli HM; O'Neal WT
Clin Cardiol; 2017 Sep; 40(9):692-696. PubMed ID: 28444995
[TBL] [Abstract][Full Text] [Related]
12. Physical Activity and Prognosis in the TOPCAT Trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist).
Hegde SM; Claggett B; Shah AM; Lewis EF; Anand I; Shah SJ; Sweitzer NK; Fang JC; Pitt B; Pfeffer MA; Solomon SD
Circulation; 2017 Sep; 136(11):982-992. PubMed ID: 28637881
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Importance of Temporal Changes in Resting Heart Rate in Heart Failure and Preserved Ejection Fraction: From the TOPCAT Study.
Vazir A; Claggett B; Pitt B; Anand I; Sweitzer N; Fang J; Fleg J; Rouleau J; Shah S; Pfeffer MA; Solomon SD
JACC Heart Fail; 2017 Nov; 5(11):782-791. PubMed ID: 29032132
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction.
Santos AB; Roca GQ; Claggett B; Sweitzer NK; Shah SJ; Anand IS; Fang JC; Zile MR; Pitt B; Solomon SD; Shah AM
Circ Heart Fail; 2016 Apr; 9(4):e002763. PubMed ID: 27056882
[TBL] [Abstract][Full Text] [Related]
15. Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function.
Beldhuis IE; Myhre PL; Bristow M; Claggett B; Damman K; Fang JC; Fleg JL; McKinlay S; Lewis EF; O'Meara E; Pitt B; Shah SJ; Vardeny O; Voors AA; Pfeffer MA; Solomon SD; Desai AS
J Am Coll Cardiol; 2021 Mar; 77(9):1211-1221. PubMed ID: 33663739
[TBL] [Abstract][Full Text] [Related]
16. Perturbations in serum chloride homeostasis in heart failure with preserved ejection fraction: insights from TOPCAT.
Grodin JL; Testani JM; Pandey A; Sambandam K; Drazner MH; Fang JC; Tang WHW
Eur J Heart Fail; 2018 Oct; 20(10):1436-1443. PubMed ID: 29893446
[TBL] [Abstract][Full Text] [Related]
17. Effect of mineralocorticoid receptor antagonists on cardiac function in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials.
Kapelios CJ; Murrow JR; Nührenberg TG; Montoro Lopez MN
Heart Fail Rev; 2019 May; 24(3):367-377. PubMed ID: 30618017
[TBL] [Abstract][Full Text] [Related]
18. Spironolactone Use and Improved Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With Resistant Hypertension.
Tsujimoto T; Kajio H
J Am Heart Assoc; 2020 Dec; 9(23):e018827. PubMed ID: 33222584
[TBL] [Abstract][Full Text] [Related]
19. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial.
Cikes M; Claggett B; Shah AM; Desai AS; Lewis EF; Shah SJ; Anand IS; O'Meara E; Rouleau JL; Sweitzer NK; Fang JC; Saksena S; Pitt B; Pfeffer MA; Solomon SD
JACC Heart Fail; 2018 Aug; 6(8):689-697. PubMed ID: 30007557
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Significance of Diabetes and Microvascular Complications in Patients With Heart Failure With Preserved Ejection Fraction.
Sandesara PB; O'Neal WT; Kelli HM; Samman-Tahhan A; Hammadah M; Quyyumi AA; Sperling LS
Diabetes Care; 2018 Jan; 41(1):150-155. PubMed ID: 29051160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
